NASDAQ
Aura Biosciences, Inc. (AURA) has a current ratio of 8.15x as of Tuesday, May 26, 2026. This represents a 52.94% decrease compared to its 12-month average of 17.31x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.